C&O Pharmaceutical Technology (Holdings) Limited was founded as a comprehensivecompany integrating R&D, production and sales in 1997. We joined the big familyof Shionogi & Co., Ltd. in 2011. Thecompany has been playing an important role among the activities of Chinesemarket during the process of globalization of the head office. A joint ventureof Ping An-Shionogi Co., Ltd. was established by Shionogi (Hong Kong) Co., Ltd.and Ping An Life Insurance Company of China, Ltd. in Shanghai in November, 2020.C&O Pharmaceutical Technology (Holdings) Limited was merged into Ping An-Shionogi Co., Ltd. becoming an important part—thegeneric drug business segment of its business in February, 2021.
The company has a high sense of corporate responsibility and always takes “saving patients” as its mission, expecting to bring benefits to more patients.
The company has a high sense of corporate responsibility and always takes “saving patients” as its mission, expecting to bring benefits to more patients.
The company has a high sense of corporate responsibility and always takes “saving patients” as its mission, expecting to bring benefits to more patients.
The company has a high sense of corporate responsibility and always takes “saving patients” as its mission, expecting to bring benefits to more patients.
The company has a high sense of corporate responsibility and always takes “saving patients” as its mission, expecting to bring benefits to more patients.
The company has a high sense of corporate responsibility and always takes “saving patients” as its mission, expecting to bring benefits to more patients.